Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

GRTX Galera Therapeutics Inc

0,145

0,00 (0,00%)

07 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Galera Therapeutics (NASDAQ:GRTX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Galera Therapeutics Charts.

Galera Therapeutics (NASDAQ:GRTX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Galera Therapeutics Charts.

News Galera Therapeutics Inc

Form 8-K - Current report
Freitag 7 Juni 2024 (16 Stunden vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 3 Juni 2024 (5 Tage vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Donnerstag 16 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Donnerstag 16 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Donnerstag 16 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 13 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates
Montag 13 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Galera Adopts Limited Duration Stockholder Rights Agreement
Freitag 3 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
Donnerstag 28 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Montag 26 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mittwoch 21 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Galera Therapeutics Inc News-Artikel

BNP Paribas (QX)

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen